Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection

Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection

A groundbreaking study by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has revealed that certain blood tests are now accurate enough to be used in clinical settings for detecting Alzheimer’s disease. This new research suggests these blood tests could replace more invasive procedures like spinal taps and brain scans for many […]

Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics

Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics

In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer’s disease, has secured an investment of up to $15 million from Eisai Inc., a globally recognized human health care company. This strategic partnership underscores a shared commitment between the two firms to […]